HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of thalidomide in the treatment of myelodysplastic syndromes.

AuthorsPier Paolo Piccaluga, Giuseppe Visani, Carlo Finelli, Tiziana Grafone, Michele Baccarani, Sante Tura
JournalHaematologica (Haematologica) Vol. 87 Issue 3 Pg. ELT18 (Mar 2002) ISSN: 0390-6078 [Print] Italy
PMID11869964 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Thalidomide
Topics
  • Aged
  • Angiogenesis Inhibitors (administration & dosage, pharmacokinetics)
  • Female
  • Humans
  • Middle Aged
  • Myelodysplastic Syndromes (drug therapy)
  • Thalidomide (administration & dosage, pharmacokinetics)
  • Therapeutic Equivalency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: